# KPRX (Kiora Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Kiora Pharmaceuticals, Inc. reported $0 in revenue and a net loss of $12.76M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

- Canonical: https://convexityos.com/fundamentals/KPRX
- Markdown: https://convexityos.com/fundamentals/KPRX.md
- SEC CIK: 0001372514
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:08 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001372514&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $0 | -100.0% YoY |
| Operating Income | FY 2025 | -$13.72M | Operating profit |
| Net Income | FY 2025 | -$12.76M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$2.03 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$7.90M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $16.29M | Total debt: $287K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $16.02M | $0 | -- | $0 | $12K | $2.69M | $1.65M | $408K | $669K |
| Research & Development | $10.78M | $7.84M | $4.03M | $3.45M | $5.35M | $3.57M | $5.39M | $8.06M | $10.33M | $8.42M |
| Total Operating Expenses | $12.83M | $11.51M | $12.59M | $12.31M | $14.24M | $8.22M | $9.80M | $12.50M | $14.97M | $14.02M |
| **Operating Income** | -$12.83M | $4.51M | -$12.59M | -$12.31M | -$14.24M | -$8.21M | -$7.11M | -$10.84M | -$14.56M | -$13.35M |
| **EBITDA** | -$12.81M | $4.53M | -$12.54M | -$12.27M | -$14.19M | -$8.18M | -$7.06M | -$10.81M | -$14.54M | -$13.34M |
| Interest Income | $894K | $1.25M | $174K | $57K | $1.1K | $23K | $108K | $120K | $564 | $3.7K |
| Interest Expense | $20K | $21K | $11K | $8.6K | $6.9K | $4.2K | $325 | $1.0K | $1.2K | $275 |
| Income Before Tax | -$12.12M | $5.66M | -$12.42M | -$13.70M | -$13.96M | -$8.08M | -$7.00M | -$10.73M | -$14.56M | -$13.34M |
| Income Tax Expense | -$1.28M | $2.07M | $90K | -$113K | -$193K | $12K | $95K | $86K | -$1.34M | $0 |
| **Net Income** | -$10.84M | $3.59M | -$12.51M | -$13.58M | -$13.77M | -$8.09M | -$7.10M | -$10.81M | -$13.22M | -$13.34M |
| Basic EPS | -$2.60 | $0.93 | -$24.25 | -$166.97 | -$21,245.10 | -$25,127.11 | -$31,657.32 | -$973,143.18 | -$3,300,595.03 | -$5,359,030.64 |
| **Diluted EPS** | -$2.64 | $0.87 | -$24.25 | -$166.97 | -$21,245.10 | -$25,127.11 | -$31,657.32 | -$973,143.18 | -$3,300,595.03 | -$5,359,030.64 |
| Basic Shares Outstanding | 4.2M | 3.9M | 538.0K | 81.4K | 648 | 322 | 224 | 11 | 4 | 2 |
| Diluted Shares Outstanding | 4.1M | 4.1M | 538.0K | 81.4K | 648 | 322 | 224 | 11 | 4 | 2 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.00M | -- | -- | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $1.95M | $2.08M | $2.12M | $2.93M | $2.73M | $2.59M | $2.53M | $1.92M |
| Total Operating Expenses | $2.69M | $2.21M | $2.51M | $7.31M | $794K | $2.40M | $2.33M | $2.56M |
| **Operating Income** | -$1.69M | -$2.21M | -$2.51M | -$7.31M | -$794K | -$2.40M | -$2.33M | -$2.56M |
| **EBITDA** | -$1.68M | -$2.20M | -$2.50M | -$7.30M | -$784K | -$2.39M | -$2.33M | -$2.56M |
| Interest Income | -- | -- | -- | -- | -- | $225K | $277K | -- |
| Income Before Tax | -$1.58M | -$2.08M | -$2.42M | -$7.17M | -$616K | -$2.26M | -$2.07M | -$2.16M |
| Income Tax Expense | $165K | $0 | $0 | -$650K | -$643K | -$112K | $123K | $2.07M |
| **Net Income** | -$1.75M | -$2.08M | -$2.42M | -$6.52M | $27K | -$2.15M | -$2.19M | -$4.22M |
| Basic EPS | -$0.28 | -$0.34 | -$0.58 | -- | $0.01 | -$0.54 | -$0.52 | -- |
| **Diluted EPS** | -$0.28 | -$0.34 | -$0.58 | -- | $0.01 | -$0.54 | -$0.52 | -- |
| Basic Shares Outstanding | 6.3M | 6.2M | 4.2M | -- | 4.3M | 4.0M | 4.2M | -- |
| Diluted Shares Outstanding | 6.3M | 6.2M | 4.2M | -- | 4.4M | 4.0M | 4.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $8.70M | $3.79M | $2.45M | $5.96M | $7.85M | $1.19M | $3.78M | $8.00M | $7.81M | $3.64M |
| Short-Term Investments | $8.39M | $23.00M | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $17.09M | $26.79M | $2.45M | $5.96M | $7.85M | $1.19M | $3.78M | $8.00M | $7.81M | $3.64M |
| Accounts Receivable, Net | $1.52M | $601K | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $21.75M | $29.71M | $4.74M | $7.68M | $8.99M | $1.73M | $4.32M | $8.48M | $8.46M | $4.15M |
| Property, Plant & Equipment, Net | $92K | $5.2K | $8.1K | $55K | $74K | $31K | $17K | $44K | $56K | $38K |
| Goodwill | -- | -- | -- | $0 | $0 | $3.48M | $1.53M | $1.53M | $1.53M | -- |
| Intangible Assets | $2.06M | $6.69M | $8.81M | $10.74M | $10.77M | $9.73M | $4.13M | $4.16M | $3.91M | -- |
| Other Non-Current Assets | $60K | $25K | $41K | $33K | $43K | $57K | $69K | $32K | $307K | $55K |
| **Total Non-Current Assets** | $2.50M | $6.78M | $8.97M | $11.00M | $11.14M | $13.43M | $5.79M | $5.80M | $5.85M | $5.58M |
| **Total Assets** | $24.25M | $36.48M | $13.71M | $18.68M | $20.13M | $15.16M | $10.11M | $14.28M | $14.31M | $9.73M |
| Accounts Payable | $1.06M | $416K | $206K | $1.01M | $161K | $435K | $210K | $64K | $706K | $1.41M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | $2.69M | $12.31M | $4.22M |
| **Total Current Liabilities** | $3.63M | $6.01M | $1.63M | $3.27M | $1.61M | $1.77M | $1.41M | $3.86M | $14.83M | $7.31M |
| Long-Term Debt | -- | -- | -- | -- | -- | $278K | $0 | -- | -- | -- |
| Deferred Revenue (Non-Current) | $1.25M | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $4.50M | $4.72M | $5.97M | $4.00M | $3.94M | $6.39M | $2.08M | $1.48M | $1.40M | $2.75M |
| **Total Liabilities** | $8.13M | $10.72M | $7.60M | $7.27M | $5.55M | $8.16M | $3.49M | $5.34M | $16.23M | $10.06M |
| **Total Debt (incl. Leases)** | $368K | $57K | $107K | $104K | $209K | $364K | $84K | $4.7K | -- | -- |
| Common Stock | $275K | $268K | $77K | $18K | $3.2K | $56K | $41K | $30K | $173K | $101K |
| Retained Earnings | -$154.2M | -$143.4M | -$147.0M | -$134.5M | -$120.9M | -$108.3M | -$100.2M | -$93.15M | -$91.82M | -$78.60M |
| Accumulated Other Comp. Income | -$246K | -$282K | -$183K | -$183K | -$86K | -$802 | $139K | $134K | $127K | $120K |
| **Total Stockholders' Equity** | $16.13M | $25.76M | $6.11M | $11.41M | $14.58M | $9.73M | $6.62M | $8.94M | -$1.93M | -$329K |
| Total Equity | $16.13M | $25.76M | $6.11M | $11.41M | $14.58M | $9.73M | $6.62M | $8.94M | $7.55M | -$329K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.57M | $7.08M | $10.96M | $8.70M | $5.51M | $1.03M | $3.77M | $3.79M |
| Short-Term Investments | $10.72M | $9.76M | $2.92M | $8.39M | $13.87M | $19.64M | $20.33M | $23.00M |
| **Cash & Short-Term Investments** | $16.29M | $16.84M | $13.87M | $17.09M | $19.38M | $20.67M | $24.11M | $26.79M |
| Accounts Receivable, Net | $637K | $1.09M | $1.54M | $1.52M | $1.21M | $2.42M | $1.34M | $601K |
| **Total Current Assets** | $19.91M | $21.26M | $18.68M | $21.75M | $22.69M | $24.74M | $27.11M | $29.71M |
| Property, Plant & Equipment, Net | $88K | $100K | $87K | $92K | $102K | $107K | $5.0K | $5.2K |
| Intangible Assets | $2.06M | $2.06M | $2.06M | $2.06M | $6.69M | $6.69M | $6.69M | $6.69M |
| Other Non-Current Assets | $84K | $85K | $88K | $60K | $58K | $61K | $64K | $25K |
| **Total Non-Current Assets** | $2.46M | $2.51M | $2.54M | $2.50M | $7.17M | $7.21M | $6.91M | $6.78M |
| **Total Assets** | $22.37M | $23.78M | $21.23M | $24.25M | $29.86M | $31.95M | $34.02M | $36.48M |
| Accounts Payable | $209K | $216K | $595K | $1.06M | $241K | $283K | $942K | $416K |
| **Total Current Liabilities** | $2.52M | $2.37M | $2.80M | $3.63M | $2.58M | $3.19M | $5.27M | $6.01M |
| Deferred Revenue (Non-Current) | $1.25M | $1.25M | $1.25M | $1.25M | $1.25M | $1.25M | -- | $0 |
| **Total Non-Current Liabilities** | $4.56M | $4.55M | $4.49M | $4.50M | $4.87M | $6.63M | $5.04M | $4.72M |
| **Total Liabilities** | $7.08M | $6.92M | $7.29M | $8.13M | $7.45M | $9.82M | $10.32M | $10.72M |
| **Total Debt (incl. Leases)** | $287K | $333K | $374K | $368K | $404K | $430K | $159K | $57K |
| Common Stock | $282K | $282K | $278K | $275K | $272K | $272K | $268K | $268K |
| Retained Earnings | -$160.5M | -$158.7M | -$156.6M | -$154.2M | -$147.7M | -$147.7M | -$145.6M | -$143.4M |
| Accumulated Other Comp. Income | -$246K | -$256K | -$229K | -$246K | -$244K | -$246K | -$297K | -$282K |
| **Total Stockholders' Equity** | $15.30M | $16.86M | $13.93M | $16.13M | $22.41M | $22.13M | $23.70M | $25.76M |
| Total Equity | $15.30M | $16.86M | $13.93M | $16.13M | $22.41M | $22.13M | $23.70M | $25.76M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$10.84M | $3.59M | -$12.51M | -$13.58M | -$13.77M | -$8.09M | -$7.10M | -$10.81M | -$13.22M | -$13.34M |
| Depreciation & Amortization | $25K | $19K | $52K | $42K | $45K | $33K | $52K | $38K | $19K | $5.2K |
| Stock-Based Compensation | $900K | $657K | $755K | $462K | $842K | $724K | $852K | $875K | $870K | $511K |
| Change in Receivables | -$922K | -$601K | $0 | -- | -- | -- | -- | -- | -- | -- |
| Change in Payables | $1.12M | $226K | -$808K | $782K | -$311K | $137K | $147K | -$642K | -$706K | $713K |
| **Operating Cash Flow** | -$9.96M | $8.56M | -$9.56M | -$10.43M | -$10.68M | -$7.32M | -$8.15M | -$10.84M | -$6.47M | -$8.41M |
| Capital Expenditure | -$111K | -$6.3K | $0 | $0 | -$64K | -$20K | $0 | -$20K | -$37K | $0 |
| **Free Cash Flow** | -$10.07M | $8.55M | -$9.56M | -$10.43M | -$10.74M | -$7.34M | -$8.15M | -$10.86M | -$6.51M | -$8.41M |
| Acquisitions, Net | -- | -- | -- | $0 | -$93K | -$111K | -- | -- | -- | -- |
| Purchases of Investments | -$8.18M | -$35.63M | $0 | -- | -- | -- | -- | -- | -- | -- |
| Sales & Maturities of Investments | $22.71M | $12.98M | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | $14.43M | -$22.66M | $0 | $6.4K | -$157K | -$244K | $0 | -$270K | -$37K | $175K |
| Common Stock Issued | -- | -- | -- | $5.38M | $17.75M | $5.00M | $1.88M | $10.11M | $10.59M | $3.77M |
| **Financing Cash Flow** | $266K | $15.50M | $5.97M | $8.62M | $17.58M | $5.00M | $3.92M | $11.30M | $10.67M | $3.50M |
| **Net Change in Cash** | $4.90M | $1.34M | -$3.55M | -$1.89M | $6.67M | -$2.59M | -$4.23M | $198K | $4.17M | -$4.73M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.75M | -$2.08M | -$2.42M | -$6.52M | $27K | -$2.15M | -$2.19M | -$4.22M |
| Depreciation & Amortization | $12K | $11K | $11K | $11K | $11K | $3.4K | $318 | $5.9K |
| Stock-Based Compensation | $186K | $109K | $210K | $234K | $254K | $263K | $149K | $160K |
| Change in Receivables | $455K | $453K | -$21K | -$310K | $1.20M | -$1.08M | -$736K | $1.18M |
| Change in Payables | -$8.1K | -$378K | -$303K | $656K | -$41K | -$662K | $1.17M | -$225K |
| **Operating Cash Flow** | -$558K | -$1.89M | -$3.16M | -$2.18M | -$1.27M | -$3.80M | -$2.70M | -$2.25M |
| Capital Expenditure | -$355 | -$23K | -$5.0K | -$78K | -$431 | -$32K | $0 | -- |
| **Free Cash Flow** | -$558K | -$1.92M | -$3.17M | -$2.26M | -$1.27M | -$3.84M | -$2.70M | -- |
| Purchases of Investments | -$2.97M | -$9.12M | $0 | $0 | $0 | -$4.56M | -$3.62M | -$6.54M |
| Sales & Maturities of Investments | $2.01M | $2.26M | $5.41M | $5.43M | $5.74M | $5.25M | $6.29M | $6.98M |
| **Investing Cash Flow** | -$958K | -$6.89M | $5.40M | $5.35M | $5.74M | $664K | $2.67M | $483K |
| **Financing Cash Flow** | -$7.4K | $4.92M | -$842 | $296 | $0 | $265K | $0 | $0 |
| **Net Change in Cash** | -$1.51M | -$3.88M | $2.26M | $3.19M | $4.48M | -$2.74M | -$21K | -$1.85M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | 28.2% | -- | -- | -- | -68104.8% | -264.7% | -656.3% | -3572.7% | -1994.3% |
| **Net Profit Margin** | -- | 22.4% | -- | -- | -- | -67102.9% | -264.2% | -654.2% | -3243.5% | -1993.8% |
| Return on Equity (ROE) | -67.2% | 14.0% | -204.8% | -119.1% | -94.5% | -83.2% | -107.2% | -121.0% | -- | -- |
| Return on Assets (ROA) | -44.7% | 9.9% | -91.3% | -72.7% | -68.4% | -53.4% | -70.2% | -75.7% | -92.4% | -137.1% |
| Current Ratio | 5.99x | 4.94x | 2.90x | 2.35x | 5.59x | 0.97x | 3.06x | 2.19x | 0.57x | 0.57x |
| Quick Ratio | 5.13x | 4.56x | 1.50x | 1.82x | 4.88x | 0.67x | 2.67x | 2.07x | 0.53x | 0.50x |
| Debt to Equity | 0.02x | 0.00x | 0.02x | 0.01x | 0.01x | 0.04x | 0.01x | 0.00x | -- | -- |
| **Revenue Growth (YoY)** | -100.0% | -- | -- | -- | -100.0% | -99.6% | +62.5% | +305.5% | -39.1% | -- |
| Operating Income Growth (YoY) | -384.5% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -401.4% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -379.6% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -216.4% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -217.8% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -100.0% | -100.0% | -100.0% | -- | -100.0% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -55210.8% | 28.2% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -60257.3% | 22.4% |
| Return on Equity (ROE) | -83.4% | -65.2% | -79.4% | -67.2% | -38.1% | -54.2% | -50.8% | 14.0% |
| Return on Assets (ROA) | -57.0% | -46.2% | -52.1% | -44.7% | -28.6% | -37.5% | -35.4% | 9.9% |
| Current Ratio | 7.91x | 8.97x | 6.68x | 5.99x | 8.79x | 7.76x | 5.14x | 4.94x |
| Quick Ratio | 6.72x | 7.56x | 5.51x | 5.13x | 7.98x | 7.25x | 4.82x | 4.56x |
| Debt to Equity | 0.02x | 0.02x | 0.03x | 0.02x | 0.02x | 0.02x | 0.01x | 0.00x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -100.0% | -100.0% | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -117.6% | -- |
| **Net Income Growth (YoY)** | -6626.6% | -- | -- | -- | -- | -- | -116.3% | -- |
| EPS Growth (YoY) | -2900.0% | -- | -- | -- | -- | -- | -111.1% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -238.4% | -- | -119.8% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
